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ABSTRACT
Background. Inguinal lymph node dissection (ILND) for
stage 3 melanoma is accompanied by high wound com-
plication rates. During the past decades, several changes in
perioperative care have been instituted to decrease the
incidence of these complications. This study aimed to
evaluate the effect of these different care protocols on
wound complications after ILND.
Methods. A retrospective analysis of prospectively col-
lected data was performed with 240 patients who
underwent an ILND in the University Medical Center
Groningen between 1989 and 2014. Four groups with dif-
ferent treatment protocols were analyzed: A (C10 days of
bed rest with a Bohler Braun splint), B (10 days of bed rest
without a splint), C (5 days of bed rest), and D (1 day of
bed rest). The effect of early mobilization, abolishment of
the Bohler Braun splint and postural restrictions, and the
introduction of prophylactic antibiotics were analyzed.
Results. One or more wound complications occurred in
51.2 % of the patients including wound infection (29.8 %),
seroma (21.5 %), wound necrosis (13.6 %), and hematoma
(5 %). In consecutive periods, respectively 44.4, 60.3, 44.9
and 55.2 % of the patients experienced wound complica-
tions. None of the instituted changes in protocols led to a
decrease in wound complications.
Conclusion. Changes in perioperative care protocols did
not affect the rate of wound complications. Perhaps a
change in the surgical procedure itself can lead to the
necessary reduction of wound complications after ILND.
For stage 3 melanoma patients, regional lymph node (LN)
dissection is the standard surgical therapy after a positive
sentinel LN biopsy [completion LN dissection (CLND)] or
clinically palpable LNs [therapeutic LN dissection (TLND)].
Unfortunately, over the decades, LN dissection of the ingu-
inal region (ILND) has been associated with high rates of
wound complications, with rates of wound infection (WI),
seroma, and wound necrosis as high as 46 %.1–4
The literature on predictive factors for postoperative
early wound complications is scarce and sometimes con-
tradictory. Factors such as age, body mass index (BMI),
smoking, comorbidities, the influence of palpable nodal
disease, and the duration of postoperative bed rest all have
been analyzed extensively.2,4–8
In the early 1970s, it was hypothesized that strict bed
rest with the use of a Bohler Braun splint during the
postoperative period would lead to edema reduction and a
decreased tension on the wound, with a potential lower
incidence of wound complications. However, treatment
protocols regarding the duration of postoperative bed rest
and the use of a Bohler Braun splint have changed over
time at our institution. Postoperative bed rest duration was
reduced to increase cost effectiveness and to decrease the
incidence of venous thrombotic events. Subsequently, from
2004 onward at our institution, prophylactic perioperative
antibiotics have been introduced, aimed at decreasing
infection rates in CLNDs.
This retrospective review of prospectively collected data
aimed to evaluate the different peri- and postoperative protocol
adjustments over the years and to evaluate their influence on
wound complications in a tertiary melanoma referral center.
MATERIALS AND METHODS
The University Medical center Groningen (UMCG) is a
melanoma referral center. Patients who underwent an
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ILND for stage 3 melanoma between 1989 and 2014 were
included in a database. The surgical procedure was either a
superficial LN dissection or a combined superficial and
deep LN dissection. Data were collected concerning patient
characteristics, tumor characteristics, the operation proce-
dure, and the postoperative period.
A single elliptical incision was used over the femoral
triangle, and skin was resected together with the superficial
specimen. The superficial specimen consisted of fat and
subcutaneous tissue between Scarpa’s fascia and the mus-
cular layer. The saphenous vein was always transected. For
the combined dissections, the inguinal ligament was divi-
ded for entrance to the deep pelvis. The deep dissection
was performed along the external iliac artery. A sartorius
flap was used, and two vacuum drains were left behind.1,2
During the entire study period, the same disinfectant,
Chloride Hexidine, was used. Since 2007, a door move-
ment protocol has been instituted, and door movements
during surgery have been strictly limited to necessary door
movements. The temperature in the operating room is
always kept at 18 C.
Histologic examination of sentinel LNs was performed
with hematoxylin-eosin (H&E) staining. If H&E staining
was positive, a combined superficial and deep LN dissec-
tion was performed. In case of a negative H&E staining,
immunohistochemical (IHC) staining for the protein S100
and HMB45 was performed. If IHC staining was positive,
the patient was considered solely for a superficial LN
dissection from 2002 onward. For patients with positive
IHC staining who underwent a CLND, an additional deep
LN dissection was performed if additional positive LNs
were found in the dissected specimen. From 2004 onward,
prophylactic perioperative antibiotics (1000 mg of intra-
venous cefazolin) were administered for all patients
scheduled for a CLND. Patients with more than three
involved nodes, a LN metastasis larger than 4 cm, or extra
capsular extension of tumor growth received adjuvant
radiotherapy (48 Gy in 20 fractions given during a maxi-
mum of 30 days) with or without trial participation.9
Wound complication was defined as a wound compli-
cation within 30 days after the ILND. The wound
complications were divided into four categories: 1 (wound
infection requiring antibiotics, surgical intervention, or
both), 2 (wound necrosis inducing secondary wound heal-
ing and/or requiring surgical intervention), 3 (seroma
formation requiring needle aspiration), and 4 (hematoma
requiring surgical intervention). Seroma was defined as a
fluctuating swelling in the inguinal area, and hematoma
was defined as a (fluctuating) swelling in the inguinal area
caused by a bleeding. An inguinal hernia requiring surgical
correction and erysipelas, urine tract infection, partial
neuropraxia, urinary retention, pulmonary embolism, or
delirium was defined as ‘‘other complication.’’
Four perioperative care protocols were used over the
years: A (C10 days of bed rest with a Bohler Braun splint),
B (10 days of bed rest without a splint), C (5 days of bed
rest), and D (1 day of bed rest). These protocols correspond
respectively with the periods 1989–2000, 2001–2005,
2006–2011, and 2012–2014. The vacuum wound drains
were removed after a minimum of 7 days and if production
was less than 20 ml per 24 h. Patients were prescribed
support stockings for the first 6 months, and low-molecu-
lar-weight heparin was administered subcutaneously (2850
IU of Fraxiparine) during immobilization.
Statistical analysis was performed with IBM SPSS ver-
sion 22.0 (IBM, Inc., Chicago, IL, USA). For continuous
variables, one-way analysis of variance (ANOVA) or the
Kruskal–Wallis test was used. Differences between nominal
variables were analyzed using the chi-square test. Variables
with a 20 % significance level in the univariate logistic
regression were entered into the multivariate regression.
Variables with a p value lower than 0.05 in the multivariate
logistic regression were identified as significant factors
associated with wound complications. The following vari-
ables were analyzed for their potential association with
wound complications according to the literature: age, gen-
der, smoking, BMI (\25 vs. 25–30 vs. [30 kg/m2),
comorbidity (diabetes mellitus, pulmonary disease, and
cardiovascular disease), CLND versus TLND, and nodal
yield. The expected nodal yield was 8 to 10 LNs for a
superficial dissection and 4 to 6 LNs for the deep dissection.
The nodal yield was entered as a categorical variable
(0–16 LNs, 17–22 LNs, and[22 LNs). The patients with a
superficial dissection only were not included in the nodal
yield analysis. The details of the operation included oper-
ation time (B130 vs. [130 min) and superficial versus
combined dissection. Operation time was defined as the
time from skin incision until skin closure. Melanoma-
specific survival (MSS) and disease-free survival (DFS)
were calculated with a Kaplan–Meier analysis. Survival
was compared between patients with and patients without a
wound complication and between patients with and
patients without a WI. The primary end point was the
occurrence of early (B30 days) postoperative wound
complications in patients after ILND. Institutional review
board approval was achieved, and the study was conducted
according to the declaration of Helsinki.
RESULTS
The study included 244 ILNDs for 239 patients (114
males and 125 females) with a median age of 56 years
(range, 5–91 years). The general clinicopathologic char-
acteristics are summarized in Table 1. The majority of the
patients (95 %) underwent a combined superficial and deep
ILND. Two patients underwent a concurrent bilateral
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ILND. Three patients underwent a bilateral superficial and
deep ILND in two separate surgical procedures.
Overall, one or more wound complications occurred
after 124 (51.2 %) of the ILNDs. Wound infection was the
most frequent complication (n = 72, 29.8 %), followed by
seroma (n = 52, 21.5 %), wound necrosis (n = 33,
13.6 %), and hematoma (n = 12, 5 %) . Antibiotics were
prescribed for 72 patients (29.8 %) postoperatively. Of
these patients, 72 experienced a WI and 4 had another
infection such as a urine tract infection. Erysipelas was
encountered during the 30-day postoperative period by 19
patients (7.9 %). Surgical intervention was performed for
seroma, hematoma, or an abscess for 49 patients (20.2 %).
Two patients (0.8 %) experienced postoperative bleeding,
which required reexploration. One patient died of a cardiac
arrest during hospitalization. Other complications occurred
for 48 patients, the majority of which were erysipelas, urine
retention, urine tract infection, and inguinal hernia.
Three patients (1.2 %) experienced a pulmonary
embolism within 3 months after surgery despite their use
of prophylactic subcutaneous heparin. No deep venous
thrombosis was seen. Two of these patients were over-
weight. The durations of bed rest for the three patients were
respectively 5, 8, and 10 days.
We observed no thromboembolic events in the group
with a short period of bed rest. More than half of the
patients (57.3 %) had a BMI higher than 25 kg/m2, and
34.7 % of the patients had more than one comorbidity.
Postoperative radiotherapy was performed for 65 patients
(26.9 %), received within 3 months after the ILND. Eight
patients (3.3 %) missed adjuvant radiotherapy due to
postoperative wound complications.
The differences between the four perioperative care
protocols are presented in Table 2. After the introduction
TABLE 1 Patient characteristics




Age (years)a 56 5–91
Location of primary tumor
Trunk 25 10.5
Genital area 4 1.7
Thigh 70 29.3
Lower leg 73 30.5
Foot 44 18.4
Mucosal 1 0.4
Unknown primary 22 9.2
Histology of primary
Superficial spreading 96 39.7
Nodular melanoma 49 20.2
Acrolentiginous 23 9.5
Unknown primary tumor 22 9.2
Otherb 17 7.0
Breslow thickness (mm) 2.5 0.6–27
T1 (B1.00) 19 7.9
T2 (1.01–2.00) 62 25.9
T3 (2.01–4.0) 81 33.9
T4 ([4.0) 53 22.2




Unknown primary 22 9.2
Comorbidity
BMI[25 137 57.3
Smoking, current 64 26.8
C1 comorbidityc 83 34.7
Diabetes mellitus 18 7.5
Cardiac disease 46 19.2
Vascular disease 38 15.9










Characteristic n % Median Range
No 168 69.4
Unknown 9 3.7
BMI body mass index
a Age at lymph node dissection
b Other is defined as verrucus, spitzoid, epitheloid, desmoplastic
melanoma and lentigo maligna melanoma
c Patients with C1comorbidity including cardiac and/or vascular and/
or pulmonary disease and/or diabetes mellitus
d Macrometastasis is defined as a palpable inguinal lymph node;
micrometastasis is defined as tumor load in the sentinel node
e Radiotherapy started within 3 months after lymph node dissection
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(n = 63) (n = 78) (n = 69) (n = 29)
Median age: years (range) 55 (20–80) 54.5 (22–86) 59 (5–91) 59 (20–74) 0.453
B55 33 52.4 41 52.6 29 42 12 41.4
[55 30 47.6 37 47.4 40 58 17 58.6
Gender 0.687
Male 30 47.6 40 51.3 29 42 15 51.7
Female 33 52.4 38 48.7 40 58 14 48.3
Smoking, current 0.347
No 43 68.3 57 73.1 50 72.5 25 86.2
Yes 20 31.7 21 26.9 19 27.5 4 13.8
Histology of primary tumor \0.001
Superficial spreading 14 22.2 29 37.7 40 58 12 41.4
Nodular melanoma 12 19.0 11 14.3 16 23.2 8 27.6
Acrolentigenous 8 12.7 10 13.0 2 2.9 3 10.3
Unknown primary tumor 7 11.1 8 10.3 5 7.2 2 6.9
Otherb 3 4.8 6 7.8 4 5.8 4 13.8









\25 25 41.0 27 36.0 33 48.5 11 37.9
25–30 30 49.2 39 52.0 24 35.3 10 34.5
[30 6 9.8 9 12.0 11 16.2 8 27.6
Diabetes mellitus 0.347
No 60 95.2 74 94.9 61 88.4 26 89.7
Yes 3 4.8 4 5.1 8 11.6 3 10.3
C1 Comorbidityc 0.332
No 42 66.7 55 70.5 44 63.8 15 51.7
Yes 21 33.3 23 29.5 25 36.2 14 48.3
Indication 0.020
Micrometastasis 18 28.6 17 21.8 25 36.2 15 51.7
Macrometastasis 45 71.4 61 78.2 44 63.8 14 48.3
Median OR time: min (range) 135 (40–285) 141 (68–254) 125 (50–248) 130 (70–195) 0.168
B130 31 49.2 30 38.5 39 56.5 15 51.7
[130 32 50.8 48 61.5 30 43.5 14 48.3
Median postoperative hospital stay: days
(range)
14 (7–34) 13 (8–45) 8 (5–47) 6 (4–14) \0.001
Radiotherapy 0.823
No 42 72.4 55 73.3 46 67.6 22 75.9
Yes 16 27.6 20 26.7 22 32.4 7 24.1
C1 Wound complication 0.173
No 35 55.6 31 39.7 38 55.1 13 44.8
Yes 28 44.4 47 60.3 31 44.9 16 55.2
Wound infection 16 24.5 22 28.2 22 31.9 12 41.4 0.448
Seroma 13 20.6 18 23.1 12 17.4 9 31 0.500
Hematoma 0 0 5 6.4 2 2.9 4 13.8
Necrosis 6 9.5 20 25.6 4 5.8 3 10.3
Complication grades 1–2d 25 71.4 50 76.9 27 67.5 17 60.7 0.333
Complication grade 3 10 28.6 15 23.1 13 32.5 11 39.3 0.093
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of SLNB, TLND was performed less frequently during the
different periods (p = 0.020).
Prophylactic antibiotics in the CLND group had no
impact on the incidence of wound complications
(p = 0.143) nor on the incidence of postoperative WIs
(p = 0.830). The institution of the door movement protocol
in 2007 did not lead to a reduction in WIs (p = 0.180). The
occurrence of wound complications did not differ between
the different perioperative care protocol groups
(p = 0.173) nor between CLND and TLND (p = 0.499).
The extent of the dissection (superficial ? deep vs super-
ficial) did not influence the incidence of wound
complications (p = 0.496). Operating time did not differ
significantly between CLND and TLND (p = 0.187).
Multivariate analysis showed increasing age to be
associated with the occurrence of wound complications
[odds ratio (OR), 1.03 per year; p = 0.035], as shown in
Table 3. The analysis showed a BMI higher than 30 kg/m2
to be independently associated with WI, as shown in
Table 4 (OR, 2.93; p = 0.013). Data on recurrence and
survival were available for 182 patients, and 57 patients
were lost to follow-up. The median MSS was worse for the
patients with a wound complication (27.4 months; range,
18.9–35.9 months) than for the patients without a wound
complication (88.8 months; p = 0.002). The median DFS
was worse for the patients with a wound complication (10.5
months; range, 6.7–14.4 months vs. 30.6 months; range,
13.7–47.5 months; p = 0.001). The median DFS for the
patients with a WI (10.5 months; range, 6.2–14.9 months)
also was worse than for the patients without a WI
(21.9 months; range, 11.5–32.3 months) (p = 0.006).
DISCUSSION
In this retrospective observational study, the different
adjustments of treatment protocols were studied over the
years with regard to their influence on the occurrence of
wound complications after an ILND. Reducing postopera-
tive bed rest did not influence the overall occurrence of
wound complications in this study.
Stuiver et al.8 in a study of 145 cases, found age to be
the only predictor for a wound complication. Reducing the
postoperative bed rest also did not influence the wound
complication rate in their study. The other studied variables
showed great similarity with those in the current study
cohort. A difference however, was the variety of surgical
techniques used by Stuiver et al.8 Due to the consistency of
the surgical procedure at our center, we are unable to
determine whether changing this procedure would have led
to a decrease in postoperative wound complications. In
accordance with the results of Stuiver et al.8 an earlier
analysis of a smaller cohort (n = 204) also did not show an
association between early mobilization and wound
complications.10
Reduction of bed rest significantly decreased the hos-
pital stay in the current study, as expected. This is in
accordance with the literature.11 It seems safe to abolish the
1-week strict bed rest. After the reduction of strict bed rest,
the use of a Bohler Braun splint and the postural restric-
tions (bed positioned with elevated legs) were abolished
from 2001 onward. Neither of these changes influenced the
occurrence of wound complications. After the postopera-











(n = 63) (n = 78) (n = 69) (n = 29)
C1 Other complication 0.613
No 51 81 62 79.5 58 84.1 21 72.4
Yes 12 19 16 20.5 11 15.9 8 27.6
Total nodal yield 0.003
0–16 34 73.9 46 64.8 25 43.1 11 42.3
17–22 10 21.7 17 23.9 18 31 6 23.1
[22 2 4.3 8 11.3 15 25.9 9 34.6
BMI body mass index, OR operating room
Group A had a Bohler Braun splint and C7 days of bed rest. Group B, C, and D had the leg elevated and no Bohler Braun splint. Group B had C7
days of bed rest. Group C had 5 or 6 days of bed rest. Group 4 had 1–4 days of bed rest
a p Values\0.05 are in bold
b Other is defined as verrucus, spitzoid, epitheloid, desmoplastic melanoma, and lentigo maligna melanoma
c Patients with C1 comorbidity included those with cardiac and/or vascular and/or pulmonary disease and/or diabetes mellitus
d Grades are for surgical complications: 1–2 mild to moderate (observation or antibiotics), 3 severe (surgical intervention)
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TABLE 3 Uni- and multivariate analyses of characteristics associated with C1 postoperative complication (n = 124)
Characteristic C1 Complications Multivariate
OR, p value (95 % CI)
% Univariate p valuea




Male 65/116 56 0.153 1.71, 0.072 (0.95–3.14)
Female 59/126 46.8
Histology of primary tumor 0.415
Superficial spreading 47 37.9
Nodular 25 20.2
Acrolentigenous 12 9.7
Unknown primary tumor 11 8.9
Other 6 4.8
BMI (kg/m2) 0.018
\25 40/98 40.8 1.00, 0.242
25–30 61/104 58.7 1.63, 0.136 (0.86–3.10)
[30 20/34 58.8 1.78, 0.236 (0.76–3.00)
Smoking
No 89/176 50.6
Yes 35/66 53 0.733
C1 Comorbidity
No 69/159 43.4
Yes 55/83 66.3 0.001 1.51, 0.236 (0.76–3.00)
Operative time (min)
B130 52/117 44.4







Yes 28/63 44.4 0.211
No 96/179 53.6
Bed in linido








Total nodal yield 0.180
0–16 60/127 47.2 1.00, 0.767
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introduction of prophylactic antibiotics before CLND from
2004 onward. This did not result in a reduction of the
wound complication rates or a reduced WI rate.
The addition of IHC staining over time has led to an
earlier detection of occult microscopic metastatic tumor
cells.12 The relative overall increase in CLNDs might also
be explained by this change in guidelines. Our finding that
a CLND versus a TLND does not influence the incidence
of wound complications is in contradiction with findings in
the literature. Faries et al.13 stated that CLND was
accompanied with less morbidity than TLND. This dif-
ference in morbidity could be explained by the difference
in extent of soft tissue dissection to clear the LN basin. Our
results showed no difference in the incidence of wound
complications between superficial and combined dissec-
tions. Due to the limited numbers of patients in the
superficial group (n = 12), no definitive conclusion can be
drawn from these results.
The institution of a door movement protocol in 2007 did
not lead to a reduction of WIs. Knobben et al.14 performed
a prospective trial at our center, in which multiple behav-
ioral changes (e.g., restriction of door movement) led to a
significant reduction of WIs. Since the introduction of the
door movement protocol, no major changes have occurred
in treatment protocols. Several patient-specific factors,
such as BMI and age, do negatively influence the occur-
rence of wound complications, although these are not
subject to intervention.
The multivariate analysis showed no association
between the different patient characteristics, the different
protocols, or the occurrence of wound complications. The
wound complication rate of 51.2 % found in this study is in
accordance with rates found in the recent literature.4,5,10,15
However, when postoperative WIs were specifically
investigated, BMI was associated with their occurrence.
Our data show a WI rate of 29.8 % compared with 45 % by
Stuiver et al. using the same definition.8 The majority of
the patients (57.3 %) in the current study were overweight.
A trend toward an increase in BMI was found in the most
recent population with stage 3 melanoma. More than 25 %
of the patients in group D had a BMI higher than 30 kg/m2
compared with approximately 10 % in the remaining
groups. The finding that BMI adds to the risk for the
development of WI is supported by the literature.4,6,10,11,16
The heterogeneity in reported wound complication rates
can probably be explained by variations in definitions used
for WI worldwide.17
Due to its retrospective nature, the wound complication
rate in this study may be lower than found in prospective
studies. As we know, immobilization increases the risk of
thromboembolic events, particularly in a population with a
high BMI.8–22 Especially in these high-risk patients, early
mobilization is of utmost importance. Our data support this
because we observed no thromboembolic events in the
group with a short period of bed rest. The significant
increase in nodal yield over the years is indicative of the
success of standardized surgical and pathologic procedures.
Several authors have reported the use of incisional
negative pressure wound therapy (INPWT) to prevent WIs
at surgical sites, including inguinal incisions.23 Prospective
randomized studies concerning the application and cost
effectiveness of INPWT in oncologic procedures such as an
ILND are scarce. Nevertheless, there might be a role for
INPWT after ILND in the future.
In conclusion, during the past decades, several adjust-
ments have been made in the treatment protocols for
patients undergoing an ILND. To date, none of these
adjustments have led to a substantial reduction in wound
complications at the UMCG. However, we have learned
that bed rest and, with that, hospital admission can be
reduced. In general, we can state that when inguinal lym-
phadenectomies are performed for patients with stage 3
melanoma at the UMCG, the occurrence of wound com-
plications for about 50 % of the patients cannot be avoided
to date.
Managing the postoperative patient after ILND with the
aim to prevent wound complications remains a challenge,
especially taking into account the negative influence of
older age and obesity on the occurrence of wound com-
plications and their expected increase in the future.24 An
ILND is a potentially curative surgical procedure, and
wound complications can hinder the most adequate treat-
ment because radiotherapy can be postponed or even
abandoned due to wound problems. Furthermore, our
TABLE 3 continued
Characteristic C1 Complications Multivariate
OR, p value (95 % CI)
% Univariate p valuea
17–22 28/51 54.9 1.00, 0.998 (0.49–2.03)
[22 20/34 58.8 1.35, 0.482 (0.59–3.07)
OR odds ratio, CI confidence interval, BMI body mass index, OR operating room
a p Values\0.05 are in bold. All variables with a significance level of p\ 0.2 in the univariate analysis were entered into the multivariate
analysis
336 M. Faut et al.
TABLE 4 Uni- and multivariate analyses of characteristics associated with wound infection (n = 72)
Characteristic Wound infection Multivariate
OR, p value (95 % CI)
% Univariate p valuea




Histology of primary tumor 0.219
Superficial spreading 29 40.3
Nodular melanoma 17 23.6
Acrolentigenous 9 12.5
Unknown primary 4 5.6
Other 4 5.6
BMI (kg/m2) 0.004
\25 21/98 21.4 1.00, 0.043
25–30 35/104 33.7 1.60, 0.158 (0.83–3.06)






Yes 33/83 39.8 1.45, 0.268 (0.75–2.80)
Operative time (min)
B130 31/117 26.5






Bohler Braun splint 0.380
Yes 16/63 25.4
No 56/179 31.3













BMI body mass index, OR operating room
a p values\0.05 are in bold. All variables with a significance level of p\ 0.2 in the univariate analysis were entered into the multivariate
analysis
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results show that both DFS and MSS are significantly
worse when a WI occurs. Preventing wound complications
is of the essence.
The inability to reduce the incidence of wound com-
plications over the years calls for drastic measures. The
most consistent variable over the years has been the sur-
gical procedure itself. Replacement of the large inguinal
incision by three smaller incisions away from the inguinal
skinfold might offer a solution via a minimally invasive
technique, namely, videoscopic inguinofemoral lym-
phadenectomy. This procedure is accompanied by a lower
complication rate in other centers and has a comparable
oncologic outcome.25–27 Because all other adjustments in
perioperative care and management have failed, this pro-
cedure might be a promising method for reducing wound
complications after ILNDs. The authors have started a trial
to study the effect of videoscopic inguinofemoral lym-
phadenectomy on postoperative complications,
lymphedema, and quality of life. The first results are
expected by early 2017.
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